Showing results (201-210 of 595) with videos related to

Sort By:
Pageof 60
International Journal of Biometeorology|October 3, 2018
Balneotherapy in chronic inflammatory rheumatic diseases-a narrative reviewFranco Cozzi, Luca Ciprian, Maria Carrara, et al.
Clinical and Experimental Rheumatology|September 22, 2022
Systemic sclerosis: one year in review 2022Gemma Lepri, Martina Orlandi, Marco Di Battista, et al.
Rheumatology (Oxford, England)|August 26, 2023
Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseasesMarion Thomas, Maeva Masson, Samuel Bitoun, et al.
Annals of the Rheumatic Diseases|December 24, 2025
From the grey area of pre-systemic sclerosis to very early disease and irreversible tissue damage: the challenge of defining at-risk patients for future preventive trials in systemic sclerosisAlain Lescoat, Yannick Allanore, Francesco Del Galdo, et al.
Drugs in R&D|April 25, 2025
Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis Treated with GP2015, an Etanercept Biosimilar: Results from Two Phase III Studies (EGALITY and EQUIRA)Diamant Thaçi, Sascha Gerdes, Hendrik Schulze-Koops, et al.
Seminars in Arthritis and Rheumatism|January 17, 2022
Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practiceJérôme Avouac, Rodolphe Cougnaud Murail, Claire Goulvestre, et al.
RMD Open|May 4, 2026
Scoping literature review on applied definitions of very early diagnosis of systemic sclerosis (VEDOSS) and pre-systemic sclerosis in original articlesAlain Lescoat, Yannick Allanore, Francesco Del Galdo, et al.
Seminars in Arthritis and Rheumatism|March 15, 2017
Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosisJérôme Avouac, Gemma Lepri, Vanessa Smith, et al.
Annals of the Rheumatic Diseases|August 19, 2019
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrualSerena Fasano, Antonella Riccardi, Valentina Messiniti, et al.
Seminars in Arthritis and Rheumatism|January 10, 2022
Erosive arthritis autoantibodies in systemic sclerosisAntonella Riccardi, Guillaume Martinroche, Cécile Contin-Bordes, et al.
Pageof 60